The good work can go on

Novo Nordisk shareholders approve additional endowment.

The work of the Foundation has received widespread accolades but the best was at the annual general assembly held in March 2008, when the shareholders of Novo Nordisk A/S approved an additional endowment of 575 million Danish Kroner (DKK) to the World Diabetes Foundation and extended the original funding period by five years i.e. up to 2017; this coming over the original grant of 500 million DKK brings the total endowment from Novo Nordisk A/S to 1.075 billion DKK equivalent to approximately USD 221 million, at current exchange rates, to be disbursed over 15 years.

This is truly good news for the poorest people with diabetes in the developing world.

Read more

Fighting diabetic foot complications

Globally, diabetes is responsible for more than 1 million amputations every year, and next to injuries caused by accidents, diabetes is the most common cause of lower limb amputations, according to the International Diabetes Federation.

A project in Karnataka, India is preventing diabetes related amputations in rural areas by taking advanced high level of technology and a committed network of volunteers into a joint collaboration.

Read more

Project Application

We encourage you to submit your application for funding of your project within our focus areas.

How to apply

Annual Review 2007

Stories in this year’s Annual Review demonstrate how  even the smallest investments and partnerships can accelerate to have a catalytic effect.

Read more

Download Annual Review

Newsletter Q1 2008 out now

Read more

Sign up for the newsletter